Literature DB >> 17070222

Nicotinamide adenine dinucleotide staining immediately following radio frequency ablation of renal tumors-is a positive stain synonymous with ablative failure?

Joshua M Stern1, J Kyle Anderson, Yair Lotan, Sangtae Park, Jeffrey A Cadeddu.   

Abstract

PURPOSE: Nicotinamide adenine dinucleotide diaphorase staining is arguably the standard for assessing tissue viability following radio frequency ablation, yet the accuracy of this test is questionable. Thus, it is imperative to examine the reliability of nicotinamide adenine dinucleotide to predict ablation success. To evaluate the observation that immediate nicotinamide adenine dinucleotide staining may not be clinically reliable, we compared results from immediate post-ablation biopsies of renal tumors to radiological and clinical followup.
MATERIALS AND METHODS: Laparoscopic radio frequency ablation was performed in 9 patients and 10 tumors using a temperature modulated radio frequency system. Cold cup biopsies were taken immediately following ablation, and processed for nicotinamide adenine dinucleotide and hematoxylin and eosin staining. Patients were then followed using contrast enhanced computerized tomography at regular intervals.
RESULTS: Median tumor size was 2.3 cm. Hematoxylin and eosin stain diagnosed 8 renal cell carcinomas and 2 angiomyolipomas. A quarter of the renal cell carcinomas and both angiomyolipomas stained positive for scattered nicotinamide adenine dinucleotide diaphorase activity immediately after RFA. Mean followup for the nicotinamide adenine dinucleotide positive tumors was 28.5 months (range 24 to 30) and for the nicotinamide adenine dinucleotide negative tumors was 25 months (range 18 to 30). There was no evidence of local tumor recurrence in any patient.
CONCLUSIONS: Four lesions had nicotinamide adenine dinucleotide diaphorase activity on post-ablation biopsy suggesting retained viable tissue, yet there has been no recurrence during an average 2-year followup. While negative nicotinamide adenine dinucleotide staining is consistent with nonviability, these results suggest that false-positive staining can occur immediately following RFA, making the predictive value of positive nicotinamide adenine dinucleotide diaphorase staining unclear.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070222     DOI: 10.1016/j.juro.2006.07.018

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Loss of cellular viability in areas of ground-glass opacity on computed tomography images immediately after pulmonary radiofrequency ablation in rabbits.

Authors:  Masaomi Kuroki; Hiroshi Nakada; Atsushi Yamashita; Akira Sawaguchi; Noriko Uchino; Shinya Sato; Taketoshi Asanuma; Yujiro Asada; Shozo Tamura
Journal:  Jpn J Radiol       Date:  2012-05       Impact factor: 2.374

2.  [Radiofrequency ablation as minimally invasive treatment for tumors : a commentary on Schultheis et al].

Authors:  T Schneider; H Dienemann
Journal:  Chirurg       Date:  2008-10       Impact factor: 0.955

3.  Mechanical fractionation of tissues using microsecond-long HIFU pulses on a clinical MR-HIFU system.

Authors:  Avinash Eranki; Navid Farr; Ari Partanen; Karun V Sharma; Christopher T Rossi; Avi Z Rosenberg; AeRang Kim; Matthew Oetgen; Haydar Celik; David Woods; Pavel S Yarmolenko; Peter C W Kim; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2018-02-22       Impact factor: 3.914

4.  Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study.

Authors:  Shanda H Blackmon; Rosalie M Sterner; Patrick W Eiken; Thomas J Vogl; Bradley B Pua; Jeffrey L Port; Damian E Dupuy; Matthew R Callstrom
Journal:  J Thorac Dis       Date:  2021-12       Impact factor: 2.895

5.  Radiofrequency ablation: a minimally invasive approach in kidney tumor management.

Authors:  Maciej Salagierski; Marek S Salagierski
Journal:  Cancers (Basel)       Date:  2010-11-17       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.